M&A Deal Summary

Novo Holdings A/S Acquires Catalent

On February 5, 2024, corporate investor Novo Holdings A/S acquired life science company Catalent for 16.5B USD

Acquisition Highlights
  • This is Novo Holdings A/S’s 6th transaction in the Life Science sector.
  • This is Novo Holdings A/S’s largest (disclosed) transaction.
  • This is Novo Holdings A/S’s 7th transaction in the United States.
  • This is Novo Holdings A/S’s 2nd transaction in New Jersey.

M&A Deal Summary
Date 2024-02-05
Target Catalent
Sector Life Science
Buyer(s) Novo Holdings A/S
Deal Type Going Private
Deal Value 16.5B USD
Advisor(s) Citigroup Investment Banking
J.P. Morgan Securities (Financial)
Skadden, Arps, Slate, Meagher & Flom (Legal)

Target

Catalent

Somerset, New Jersey, United States
Catalent is a provider of solutions for drugs, biologics and consumer health products. Among its core offerings, it develops and manufactures oral and sterile medication in nearly all dosage forms, holds patents for softgel (e.g. “Liqui-Caps” and “Vegicaps”) and Zydis fast-dissolve technologies used in many popular prescription and over-the-counter medicine. Catalent was founded in 2007 and is based in Somerset, New Jersey.

Search 200,291 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Novo Holdings A/S

Investor Investor Investor Investor Investor

Category Corporate Investor
Founded 1999
Size Middle-Market
Type Sector Focused
DESCRIPTION

Novo Holdings A/S is a Danish holding company and the investment arm of the Novo Nordisk Foundation. Novo Holdings' objective is to grow the assets of the Foundation and improve the lives of people around the world. In addition to investing in equity and fixed income securities, Novo Holdings pursues direct investments in life science companies. Novo Holdings A/S was established in 1999 and is headquartered in Hellerup, Denmark.

DEAL STATS #
Overall 13 of 15
Sector (Life Science) 6 of 6
Type (Going Private) 2 of 2
State (New Jersey) 2 of 2
Country (United States) 7 of 7
Year (2024) 2 of 4
Size (of disclosed) 1 of 4
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2024-01-10 All West Communications

Kamas, Utah, United States

All West Communications is a provider of telecommunication services. All West Communications operate a broadband-powered network to deliver services that connect people and businesses to what matters most across town and around the world. All West Communications was founded in 1912 and is based in Kamas, Utah.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2024-05-15 Single Use Support

Kufstein, Austria

Single Use Support is a process solution provider specializing in fluid and cold chain management of drug substances. The company focuses on developing solutions to provide manufacturers with 100% safe and efficient handling, liquid transfer, freezing, and cold chain shipping of advanced therapies and biologics in pharmaceutical production. Single Use Support Gmbh was founded in 2016 and is based in Kufstein, Germany.

Buy -
Mergr

Product

Company

Legal